Fmoc-L-Asp-OtBu

Fmoc-L-Asp-OtBu is an Fmoc-protected L-aspartic acid tert-butyl ester that combines an N-(9H-fluoren-9-ylmethoxycarbonyl) urethane with a side-chain carboxyl protected as a tert-butyl ester. The molecule therefore presents a stereogenic center at the alpha carbon in the L-configuration, while bearing two carboxyl-derived functional motifs that are orthogonally protected for peptide chemistry: an acid-labile tert-butyl group on the side chain and a base-stable Fmoc group on the amino terminus. The protected carboxyl/ester framework supports controlled deprotection and subsequent conversion to amide or activated acid derivatives, enabling reliable incorporation of Asp residues into peptide sequences. The presence of a bulky tert-butyl ester and the aromatic Fmoc chromophore also supports chromatographic handling and downstream analytical tracking during protected amino acid synthesis and peptide assembly.

1. Peptide Synthesis

Fmoc-L-Asp-OtBu is used in solid-phase peptide synthesis and solution-phase peptide coupling workflows where orthogonal protection of the Asp side-chain carboxyl is required. The Fmoc-protected alpha-amino group supports base-mediated removal to generate a free amine for stepwise peptide bond formation, while the tert-butyl ester on the side chain remains intact under typical Fmoc deprotection conditions. The resulting Asp side-chain carboxyl can be revealed under acid conditions, permitting subsequent coupling, side-chain functionalization, or formation of aspartyl linkages in peptide analogs. The L-stereochemistry is preserved through the building-block design, supporting stereochemically defined peptide products for biochemical research and synthetic methodology development.

2. Side-Chain Functionalization

Fmoc-L-Asp-OtBu is suitable for side-chain functionalization strategies that convert the Asp side-chain carboxyl into activated intermediates or conjugation handles after selective deprotection. The tert-butyl ester protection enables controlled generation of the free side-chain carboxyl under acidic conditions, after which the carboxyl can participate in carbodiimide-mediated amidation, esterification, or formation of mixed anhydrides for controlled derivatization. The presence of an Fmoc group allows the amino terminus to remain protected during side-chain chemistry, reducing competing reactions and supporting sequential modification schemes. Downstream uses include preparation of peptide conjugates, linker-bearing Asp-containing fragments, and structured molecular scaffolds for chemical biology and materials-facing research.

3. Drug Discovery SAR Studies

Fmoc-L-Asp-OtBu can be applied to structure-activity relationship studies by enabling the synthesis of Asp-containing peptidomimetics and constrained peptide fragments used in medicinal chemistry screening. The protected amino acid architecture supports incorporation of a stereodefined acidic side chain into libraries where the Asp carboxyl participates in hydrogen bonding, salt-bridge formation, or metal coordination motifs. The orthogonal deprotection logic supports late-stage diversification, allowing side-chain conversion to amides, esters, or other carboxyl derivatives while maintaining an Fmoc-compatible synthetic timeline. The resulting Asp-functional scaffolds can be used as building blocks for analog generation and for mapping structure-dependent binding features in SAR workflows.

4. Protein Engineering

Fmoc-L-Asp-OtBu is employed in protein engineering contexts that require defined incorporation of Asp residues into peptide segments used for mapping interfaces, generating binding probes, or constructing recombinant protein mimics. The L-aspartate stereochemistry and protected functional groups support assembly of peptide domains that preserve the spatial orientation of the side-chain carboxylate. The Fmoc/tert-butyl orthogonality can be leveraged to install Asp at specific positions while allowing selective exposure of the side-chain carboxyl for subsequent conjugation or crosslinking chemistry. The generated Asp-containing peptide materials serve as chemically defined components for downstream protein-interaction studies and engineered biomolecule construction.

5. Pharmaceutical Manufacturing

Fmoc-L-Asp-OtBu is relevant to pharmaceutical manufacturing and fine chemical production where protected amino acid intermediates are required for controlled peptide intermediate preparation. The Fmoc-protected amine and tert-butyl-protected side-chain carboxyl provide a protection strategy compatible with industrially scalable peptide synthesis operations, supporting predictable deprotection and coupling behavior. The aromatic Fmoc group can assist in monitoring and purification steps during intermediate handling, while the orthogonal ester protection supports conversion of the Asp side chain into the correct functional form at the appropriate stage. The compound thus functions as a process-compatible amino acid building block for generating Asp-containing peptide intermediates used in manufacturing pipelines and applied synthetic chemistry.

6. Analytical Research Standards

Fmoc-L-Asp-OtBu can be utilized for analytical research and method development requiring chemically defined Asp-containing standards or derivatization substrates. The stable Fmoc chromophore and protected carboxyl functionality enable consistent chromatographic behavior and facilitate mass spectrometric identification of protected Asp species and their deprotected counterparts. Controlled deprotection of the tert-butyl ester can generate reference free-carboxyl Asp derivatives, supporting calibration of analytical workflows that distinguish protected versus deprotected forms. The compound therefore supports routine quality assessment, impurity profiling, and characterization of peptide synthesis intermediates in amino acid chemistry and peptide science.

1. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I